Detalles de la búsqueda
1.
Future Burden of Ischemic Stroke in Australia: Impact on Health Outcomes between 2019 and 2038.
Neuroepidemiology
; : 1-11, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38599203
2.
Current and Future Cost Burden of Ischemic Stroke in Australia: Dynamic Model.
Neuroepidemiology
; 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38560982
3.
Acute kidney injury, renal impairment and renal failure associated with sodium glucose co-transporter-2 inhibitors in at-risk groups: A systematic review.
Br J Clin Pharmacol
; 2024 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38784979
4.
Global trends in the incidence of hospital admissions for diabetes-related foot disease and amputations: a review of national rates in the 21st century.
Diabetologia
; 66(2): 267-287, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36512083
5.
Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis.
Diabetologia
; 66(4): 642-656, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36404375
6.
Long-term cost-effectiveness of implementing a lifestyle intervention during pregnancy to reduce the incidence of gestational diabetes and type 2 diabetes.
Diabetologia
; 66(7): 1223-1234, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36932207
7.
Trends in the Incidence of End-Stage Kidney Disease in Type 1 and Type 2 Diabetes in Australia, 2010-2019.
Am J Kidney Dis
; 82(5): 608-616, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37487818
8.
Targeting Diabetes Prevention to More Disadvantaged Groups Improves Cost-Effectiveness: Implications of Inequality in Type 2 Diabetes From Theoretical Interventions.
Value Health
; 26(7): 974-983, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36801245
9.
Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification.
Value Health
; 26(4): 498-507, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36442832
10.
Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts.
Diabetologia
; 65(6): 964-972, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35314870
11.
Persistent disparities in diabetes medication receipt by socio-economic disadvantage in Australia.
Diabet Med
; 39(9): e14898, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35694847
12.
Excess all-cause and cause-specific mortality for people with diabetes and end-stage kidney disease.
Diabet Med
; 39(6): e14775, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951712
13.
Changes in excess mortality among adults with diabetes-related end-stage kidney disease: a comparison between the USA and Australia.
Nephrol Dial Transplant
; 37(10): 2004-2013, 2022 09 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34724066
14.
The association of socioeconomic disadvantage and remoteness with receipt of type 2 diabetes medications in Australia: a nationwide registry study.
Diabetologia
; 64(2): 349-360, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33078206
15.
Health economics of detection and treatment of children with familial hypercholesterolemia: to screen or not to screen is no longer the question.
Curr Opin Endocrinol Diabetes Obes
; 31(2): 84-89, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37983310
16.
Lipid-Lowering Strategies for Primary Prevention of Coronary Heart Disease in the UK: A Cost-Effectiveness Analysis.
Pharmacoeconomics
; 42(1): 91-107, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606881
17.
Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia.
Eur J Prev Cardiol
; 31(5): 580-588, 2024 Mar 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37987181
18.
No effect of remoteness on clinical outcomes following myocardial infarction: An analysis of 43,729 myocardial infarctions in Victoria, Australia.
Int J Cardiol
; 398: 131593, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37979791
19.
SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors.
Clin Pharmacol Ther
; 115(6): 1304-1315, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38333984
20.
The impact of frailty on initiation, continuation and discontinuation of secondary prevention medications following myocardial infarction.
Arch Gerontol Geriatr
; 122: 105370, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38367524